Largo, Florida-based NuNature Labs said it has been authorized to distribute two medical-grade oral CBD products in Brazil. Approval is through the National Health Surveillance Agency (ANVISA), which is responsible for pharmaceuticals and health services in Brazil. Under Brazilian rules, the products can only be prescribed when other therapeutic options have been exhausted. They will be available through pharmacies. The authorization does not require proven results from clinical trials for a five-year period, according to NuNature.
Posted By: HempToday® July 16, 2021
Like HempToday? How you can support us
Your donations help us to keep HempToday open for all readers, regardless of what they can afford to pay. Through this “information equality” we're able to support hemp entrepreneurs and stakeholders all over the world by keeping a spotlight on hemp and all the promise it offers for economic development and healing our planet.